Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19361211 | 0.85 | CYP3A4 (0.30) | CYP3A4 | |
| SCHEMBL31169568 | 0.74 | — | — | |
| SCHEMBL31169570 | 0.74 | — | — | |
| SCHEMBL12516833 | 0.71 | — | — | |
| SCHEMBL12459505 | 0.68 | CYP3A4 (0.31) | CYP3A4 | |
| SCHEMBL12459119 | 0.67 | CYP3A4 (0.32) | CYP3A4 | |
| Dehydrocostuslactone SCHEMBL31029489 | 0.62 | CYP19A1 (0.46) | CYP3A4 | |
| Dehydrocostuslactone SCHEMBL699070 | 0.62 | CYP19A1 (0.46) | CYP3A4 | |
| Mokko Lactone SCHEMBL29409720 | 0.61 | MEN1 (0.42) | — | |
| Mokko Lactone SCHEMBL30171369 | 0.61 | MEN1 (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260109744-A1 | AMYLOID PEPTIDE VARIANTS | LOYOLA MARYMOUNT UNIV (US) | 2026-04-23 | — | — | US | disclosed |
| EP-4686478-A1 | QBP1 FOR USE IN THE TREATMENT AND/OR PREVENTION OF TYPE 2 DIABETES | Consejo Superior de Investigaciones Científicas (CSIC) (ES) | 2026-02-04 | — | — | EP | disclosed |
| EP-4686725-A1 | AMYLOID INHIBITORY PEPTIDES | Technische Universität München, in Vertretung des Freistaats Bayern (DE) | 2026-02-04 | — | — | EP | disclosed |
| US-12522635-B2 | Amyloid peptide variants | LOYOLA MARYMOUNT UNIVERSITY (US) | 2026-01-13 | — | — | US | disclosed |
| US-12336987-B2 | Quinoline amides and methods of using same | YALE UNIVERSITY (US) | 2025-06-24 | — | — | US | disclosed |
| CN-120136187-A | Ternary positive electrode material, preparation method thereof and electrochemical device | 南通瑞翔新材料有限公司 | 2025-06-13 | — | — | CN | disclosed |
| US-20250161408-A1 | PEPTIDIC INHIBITORS OF AMYLOID SELF- AND CROSS-ASSEMBLY | LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) | 2025-05-22 | — | — | US | disclosed |
| US-20250026838-A1 | METHODS OF PREVENTING PROTEIN AGGREGATION | TRUEBINDING, INC. | 2025-01-23 | — | — | US | disclosed |
| CN-113679726-B | Application of red sage root extract and quinone compound in resisting coronavirus | 上海科技大学 | 2025-01-10 | — | — | CN | disclosed |
| EP-4482852-A1 | PEPTIDIC INHIBITORS OF AMYLOID SELF- AND CROSS-ASSEMBLY | Technische Universität München (DE) | 2025-01-01 | — | — | EP | disclosed |
| CN-112424225-B | anti-PD-L1 antibodies and uses thereof | 桂林三金药业股份有限公司 | 2023-08-11 | — | — | CN | disclosed |
| CN-115947991-A | Amorphous phase polypropylene composition with strong lubrication and high yield elongation and preparation method thereof | 重庆会通科技有限公司 | 2023-04-11 | — | — | CN | disclosed |
| US-20230095144-A1 | AMYLOID INHIBITORY PEPTIDES | Technische Universität München (DE) | 2023-03-30 | — | — | US | disclosed |
| EP-3368505-B1 | QUINOLINE AMIDES AND METHODS OF USING SAME | UNIV YALE (US) | 2023-02-22 | — | — | EP | disclosed |
| WO-2023288252-A1 | METHODS OF PREVENTING PROTEIN AGGREGATION | TRUEBINDING, INC. (US) | 2023-01-19 | — | — | WO | disclosed |
| CN-115361961-A | Method for preventing or treating pancreatic dysfunction or diabetes by up-regulating human cathepsin LL-37 to inhibit islet amyloid polypeptide (IAPP) self-assembly | 斯坦福大学托管董事会 | 2022-11-18 | — | — | CN | disclosed |
| US-11498943-B2 | Amyloid inhibitory peptides | Technische Universität München (DE) | 2022-11-15 | — | — | US | disclosed |
| CN-113178614-B | Composite solid electrolyte, solid lithium battery and preparation method | 深圳市合壹新能技术有限公司 | 2022-11-04 | — | — | CN | disclosed |
| CN-114830374-A | Method for manufacturing or recycling member for electrochemical device, method for manufacturing electrochemical device, member for electrochemical device, and electrochemical device | 日本瑞翁株式会社 | 2022-07-29 | — | — | CN | disclosed |
| US-20220119468-A1 | AMYLOID PEPTIDE VARIANTS | LOYOLA MARYMOUNT UNIVERSITY | 2022-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230095144-A1 | AMYLOID INHIBITORY PEPTIDES | IAPP, APP, APBA1 | PTPN1 3112/4885CYP3A4 4855/4885 |
| US-20260109744-A1 | AMYLOID PEPTIDE VARIANTS | IAPP, APP, SPPL2B | PTPN1 966/4885CYP3A4 4426/4885 |
| US-12336987-B2 | Quinoline amides and methods of using same | IAPP, AMY2A, APP | PTPN1 3722/4885CYP3A4 3924/4885 |
| US-11498943-B2 | Amyloid inhibitory peptides | IAPP, APP, APBA1 | PTPN1 3112/4885CYP3A4 4855/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.